Loading...
Century Sage Scientific Holdings Limited
1450.HK•HKSE
Technology
Software - Application
HK$1.05
HK$0.03(2.94%)
Century Sage Scientific Holdings Limited (1450.HK) Financial Performance & Income Statement Overview
Review Century Sage Scientific Holdings Limited’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
16.40%
↑ 16.40%
Operating Income Growth
-26.67%
↓ 26.67%
Net Income Growth
-31.60%
↓ 31.60%
Operating Cash Flow Growth
-100.00%
↓ 100.00%
Operating Margin
15.40%
↑ 15.40%
Gross Margin
47.92%
↑ 47.92%
Net Profit Margin
6.53%
↑ 6.53%
ROE
19.75%
↑ 19.75%
ROIC
42.50%
↑ 42.50%
Century Sage Scientific Holdings Limited (1450.HK) Income Statement & Financial Overview
Review Century Sage Scientific Holdings Limited's (1450.HK) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $628.44M | $622.06M | $641.65M | $432.68M |
| Cost of Revenue | $349.74M | $301.46M | $326.08M | $188.32M |
| Gross Profit | $278.71M | $320.60M | $315.58M | $244.36M |
| Gross Profit Ratio | $0.44 | $0.52 | $0.49 | $0.56 |
| R&D Expenses | $6.59M | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $274.01M | $234.95M | $246.04M | $196.12M |
| Operating Expenses | $171.81M | $234.95M | $169.80M | $191.25M |
| Total Costs & Expenses | $521.54M | $536.41M | $495.87M | $379.57M |
| Interest Income | $0.00 | $0.00 | $8.20M | $4.91M |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $1.39M | $9.55M | $7.18M | $3.76M |
| EBITDA | $7.60M | $112.27M | $85.81M | $59.42M |
| EBITDA Ratio | $0.01 | $0.18 | $0.13 | $0.12 |
| Operating Income | $106.90M | $85.65M | $145.78M | $48.24M |
| Operating Income Ratio | $0.17 | $0.14 | $0.23 | $0.11 |
| Other Income/Expenses (Net) | -$102.80M | $11.77M | -$54.46M | -$41000.00 |
| Income Before Tax | $4.10M | $97.42M | $91.32M | $48.20M |
| Income Before Tax Ratio | $0.007 | $0.16 | $0.14 | $0.11 |
| Income Tax Expense | $15.68M | $13.60M | $20.60M | $4.95M |
| Net Income | -$3.37M | $85.08M | $75.28M | $44.18M |
| Net Income Ratio | -$0.005 | $0.14 | $0.12 | $0.10 |
| EPS | -$0.003 | $0.06 | $0.05 | $0.03 |
| Diluted EPS | -$0.003 | $0.06 | $0.05 | $0.03 |
| Weighted Avg Shares Outstanding | $1.33B | $1.38B | $1.38B | $1.38B |
| Weighted Avg Shares Outstanding (Diluted) | $1.37B | $1.38B | $1.38B | $1.38B |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan